Baxter Presents Clinical Efficacy Results from Phase III Study of …
March 11, 2010 — JesseBaxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu …MarketWatch (press release)DEERFIELD, Ill., Mar 11, 2010 (BUSINESS WIRE) — Baxter International Inc. (NYSE:BAX) , in conjunction with DynPort Vaccine …
Read the original:
Baxter Presents Clinical Efficacy Results from Phase III Study of …